Boston, MA. Northeastern University’s Center for Research Innovation (CRI) has announced its participation in AdvaMed 2012 as part of its continued commitment to serving Northeastern University’s innovation community.
With inventions surfacing at a record pace, Northeastern ‘s reputation as a source for relevant innovations is continuing to grow. CRI leads the translation of University innovations to high impact solutions by leveraging entrepreneurship and commercialization strategies. Participation in AdvaMed 2012 (over 1900 participants) will create additional opportunities in the Medtech vertical while continuing to increase the visibility of Northeastern University’s commitment to high impact innovation. Highlights of the convention include meetings with C-suite individuals of significant companies representing the Medtech Industry, participation with other highly regarded entities in the Massachusetts Pavilion, and the ability to gain insight into the most up-to-date technological advances in the medical field.
CRI recently attended BIO 2012 (over 15,000 participants) with a similar mission of continuing to develop corporate relationships across the Bio-tech and Pharmaceutical Industries. These meetings produced significant relationships that, with the help of CRI, are fostering collaborations between NU innovators and big name corporations, helping to bring NU innovations to the marketplace.
About Northeastern University’s Center for Research Innovation
Northeastern University’s Center for Research Innovation (CRI) is a catalyst for the transformation of Northeastern’s use-inspired innovations into high impact solutions. CRI has a wide range of life science technologies available for licensing, including portfolios of small molecules for therapeutic use; nano and microparticle compositions for therapeutic and/or diagnostic applications; devices for therapeutic and preventive use, diagnostics tailored to in-clinic and at home use; tools and equipment for research and clinical applications; and software for diagnostic and individualized wellness assessments.
In its 6th year, AdvaMed 2012 provides a unique environment for its member companies to meet and foster relationships leading to collaborations and investments. These member companies produce medical devices, diagnostic products and health information systems that are transforming health care through early disease detection, less invasive procedures and more effective treatments. AdvaMed 2012 participants represent 22 countries and will take place October 1-3 in Boston, MA.
Center for Research Innovation
900 Renaissance Park
Boston, MA 02115